SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905718-20-000990
Filing Date
2020-09-28
Accepted
2020-09-28 16:09:16
Documents
2
Group Members
ABINGWORTH BIOVENTURES VII, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D nucana_13dsep172020.htm SC 13D 51022
2 EX-1 nucana_13dsep172020ex1.htm EX-1 9261
  Complete submission text file 0000905718-20-000990.txt   61828
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Subject) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90138 | Film No.: 201204424
SIC: 2834 Pharmaceutical Preparations